Agios Pharmaceuticals, Inc. (AGIO)

NASDAQ

$26.86

-$0.41 (1.52%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$26.52$27.95

Open $27.60

52 Week Range

$22.24$46.00

Previous Close $27.27

Market Cap1.57B

Volume931.96K

Avg Volume1.23M

P/E (TTM)-3.89

EPS (TTM)$-6.90

Dividend / YieldN/A

Dividend StreakN/A

Analyst Ratings & Targets

Price Target

Consensus Target

$36.75

Based on 5 analysts (last year)

High Target

$56.00

Low Target

$25.00

Current

$26.86

Target

$36.75

$25.00$56.00

Potential upside of 36.85%

Based on consensus price target

Price Target Timeframes

Last Month

$30.33

3 analysts

Last Quarter

$36.75

4 analysts

Last Year

$43.60

5 analysts

All Time

$47.33

15 analysts

Analyst Consensus

Current Consensus

Buy

Based on 28 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

(Score: 2)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows1/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity1/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits1/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Nov 24, 2025	Unknown	Truist Financial	$32.00	$25.24	+26.78%
Nov 20, 2025	Unknown	Goldman Sachs	$25.00	$25.55	-2.15%
Nov 20, 2025	Unknown	Leerink Partners	$34.00	$22.34	+52.19%
Oct 20, 2025	Emily Bodnar	H.C. Wainwright	$56.00	$42.33

Recent Analyst Actions


Nov 21, 2025	Maintained	JP Morgan	Neutral	Neutral
Nov 20, 2025	Maintained	B of A Securities	Buy	Buy
Nov 20, 2025	Upgrade	Leerink Partners	Market Perform	Outperform
Nov 20, 2025	Maintained	Goldman Sachs	Neutral	Neutral
Nov 20, 2025	Maintained	HC Wainwright & Co.	Buy	Buy

Showing 1 to 5 of 174 entries

Analyst Ratings & Targets

Price Target

Consensus Target

$36.75

Based on 5 analysts (last year)

High Target

$56.00

Low Target

$25.00

Current

$26.86

Target

$36.75

$25.00$56.00

Potential upside of 36.85%

Based on consensus price target

Price Target Timeframes

Last Month

$30.33

3 analysts

Last Quarter

$36.75

4 analysts

Last Year

$43.60

5 analysts

All Time

$47.33

15 analysts

Analyst Consensus

Current Consensus

Buy

Based on 28 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

(Score: 2)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows1/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity1/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits1/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Nov 24, 2025	Unknown	Truist Financial	$32.00	$25.24	+26.78%
Nov 20, 2025	Unknown	Goldman Sachs	$25.00	$25.55	-2.15%
Nov 20, 2025	Unknown	Leerink Partners	$34.00	$22.34	+52.19%
Oct 20, 2025	Emily Bodnar	H.C. Wainwright	$56.00	$42.33

Recent Analyst Actions


Nov 21, 2025	Maintained	JP Morgan	Neutral	Neutral
Nov 20, 2025	Maintained	B of A Securities	Buy	Buy
Nov 20, 2025	Upgrade	Leerink Partners	Market Perform	Outperform
Nov 20, 2025	Maintained	Goldman Sachs	Neutral	Neutral
Nov 20, 2025	Maintained	HC Wainwright & Co.	Buy	Buy

Showing 1 to 5 of 174 entries